Literature DB >> 35373283

Patchwork Cancer Predisposition.

L Alexander Liggett1,2, Vijay G Sankaran1,2,3.   

Abstract

SUMMARY: Inherited genetic variation is increasingly identified as an important predisposing factor to a variety of cancers. In this issue of Cancer Discovery, Pareja and colleagues developed a method of reliably detecting mosaic cancer susceptibility mutations in patients who have been sequenced as part of the MSK-IMPACT tumor profiling platform. This led to the identification of a number of mosaic mutations in cancer susceptibility alleles that are generally found in the germline, suggesting that many predisposition variants may be missed through conventional testing. See related article by Pareja et al., p. 949 (6). ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 35373283      PMCID: PMC8988512          DOI: 10.1158/2159-8290.CD-22-0025

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  10 in total

Review 1.  P53 and prognosis: new insights and further complexity.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 2.  BRCA1 and BRCA2: different roles in a common pathway of genome protection.

Authors:  Rohini Roy; Jarin Chun; Simon N Powell
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

3.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

Authors:  Donavan T Cheng; Talia N Mitchell; Ahmet Zehir; Ronak H Shah; Ryma Benayed; Aijazuddin Syed; Raghu Chandramohan; Zhen Yu Liu; Helen H Won; Sasinya N Scott; A Rose Brannon; Catherine O'Reilly; Justyna Sadowska; Jacklyn Casanova; Angela Yannes; Jaclyn F Hechtman; Jinjuan Yao; Wei Song; Dara S Ross; Alifya Oultache; Snjezana Dogan; Laetitia Borsu; Meera Hameed; Khedoudja Nafa; Maria E Arcila; Marc Ladanyi; Michael F Berger
Journal:  J Mol Diagn       Date:  2015-03-20       Impact factor: 5.568

4.  Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes.

Authors:  Shunsuke Kon; Kojiro Ishibashi; Hiroto Katoh; Sho Kitamoto; Takanobu Shirai; Shinya Tanaka; Mihoko Kajita; Susumu Ishikawa; Hajime Yamauchi; Yuta Yako; Tomoko Kamasaki; Tomohiro Matsumoto; Hirotaka Watanabe; Riku Egami; Ayana Sasaki; Atsuko Nishikawa; Ikumi Kameda; Takeshi Maruyama; Rika Narumi; Tomoko Morita; Yoshiteru Sasaki; Ryosuke Enoki; Sato Honma; Hiromi Imamura; Masanobu Oshima; Tomoyoshi Soga; Jun-Ichi Miyazaki; Michael R Duchen; Jin-Min Nam; Yasuhito Onodera; Shingo Yoshioka; Junichi Kikuta; Masaru Ishii; Masamichi Imajo; Eisuke Nishida; Yoichiro Fujioka; Yusuke Ohba; Toshiro Sato; Yasuyuki Fujita
Journal:  Nat Cell Biol       Date:  2017-04-17       Impact factor: 28.824

Review 5.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

6.  Human-tumor-derived cell lines contain common and different transforming genes.

Authors:  M Perucho; M Goldfarb; K Shimizu; C Lama; J Fogh; M Wigler
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

7.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

8.  Cancer-Causative Mutations Occurring in Early Embryogenesis.

Authors:  Fresia Pareja; Ryan N Ptashkin; David N Brown; Fatemeh Derakhshan; Pier Selenica; Edaise M da Silva; Andrea M Gazzo; Arnaud Da Cruz Paula; Kelsey Breen; Ronglai Shen; Antonio Marra; Ahmet Zehir; Ryma Benayed; Michael F Berger; Ozge Ceyhan-Birsoy; Sowmya Jairam; Margaret Sheehan; Utsav Patel; Yelena Kemel; Jacklyn Casanova-Murphy; Christopher J Schwartz; Mahsa Vahdatinia; Elizabeth Comen; Laetitia Borsu; Xin Pei; Nadeem Riaz; David H Abramson; Britta Weigelt; Michael F Walsh; Anna-Katerina Hadjantonakis; Marc Ladanyi; Kenneth Offit; Zsofia K Stadler; Mark E Robson; Jorge S Reis-Filho; Diana Mandelker
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

Review 9.  Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers.

Authors:  Giulia Federici; Silvia Soddu
Journal:  J Exp Clin Cancer Res       Date:  2020-03-04

10.  Mutational processes molding the genomes of 21 breast cancers.

Authors:  Serena Nik-Zainal; Ludmil B Alexandrov; David C Wedge; Peter Van Loo; Christopher D Greenman; Keiran Raine; David Jones; Jonathan Hinton; John Marshall; Lucy A Stebbings; Andrew Menzies; Sancha Martin; Kenric Leung; Lina Chen; Catherine Leroy; Manasa Ramakrishna; Richard Rance; King Wai Lau; Laura J Mudie; Ignacio Varela; David J McBride; Graham R Bignell; Susanna L Cooke; Adam Shlien; John Gamble; Ian Whitmore; Mark Maddison; Patrick S Tarpey; Helen R Davies; Elli Papaemmanuil; Philip J Stephens; Stuart McLaren; Adam P Butler; Jon W Teague; Göran Jönsson; Judy E Garber; Daniel Silver; Penelope Miron; Aquila Fatima; Sandrine Boyault; Anita Langerød; Andrew Tutt; John W M Martens; Samuel A J R Aparicio; Åke Borg; Anne Vincent Salomon; Gilles Thomas; Anne-Lise Børresen-Dale; Andrea L Richardson; Michael S Neuberger; P Andrew Futreal; Peter J Campbell; Michael R Stratton
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.